Miral Dental Clinics Co. said its bottom line rose to SAR 8.3 million in H1 2025, from SAR 6.5 million in H1 2024.
| Item | H1 2024 | H1 2025 | Change |
|---|---|---|---|
| Revenues | 33.98 | 38.87 | 14.4 % |
| Gross Income | 12.15 | 14.12 | 16.3 % |
| Operating Income | 8.00 | 8.36 | 4.4 % |
| Net Income | 6.54 | 8.28 | 26.6 % |
| Average Shares | 2.00 | 2.00 | - |
| Earnings Per Share before unusual items (Riyal) | 3.84 | 4.14 | 7.8 % |
| EPS (Riyal) | 3.27 | 4.14 | 26.6 % |
| Item | H2 2024 | H1 2025 | Change |
|---|---|---|---|
| Revenues | 40.47 | 38.87 | (4.0 %) |
| Gross Income | 15.50 | 14.12 | (8.9 %) |
| Operating Income | 10.37 | 8.36 | (19.4 %) |
| Net Income | 10.17 | 8.28 | (18.6 %) |
| Average Shares | 2.00 | 2.00 | - |
| Earnings Per Share before unusual items (Riyal) | 5.08 | 4.14 | (18.6 %) |
| EPS (Riyal) | 5.08 | 4.14 | (18.6 %) |
The earnings growth was driven by higher revenue from an expanded customer base and increased demand for dental services. This was supported by the company’s high-quality services, qualified medical staff, adoption of advanced technologies and equipment, a wide range of therapeutic and cosmetic offerings, and improved operational efficiency.
Sequentially, H1 2022 profit declined by 18.6% from SAR 10.17 million in H2 2024.
Shareholders' equity, with no minority interest, rose to SAR 67.66 million as of June 30, 2025, compared to SAR 49.42 million in the prior-year period.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: